Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ: MDGL · Real-Time Price · USD

579.89

+6.74 (1.18%)

At close: Dec 3, 2025, 4:00 PM EST

579.00

-0.89 (-0.15%)

After-hours: Dec 3, 2025, 7:41 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2004 - 2008
Period Ending	Dec '24 Dec 31, 2024	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	2004 - 2008
Novel Therapeutics	180.13M	Log In	Log In	Log In	Log In	Upgrade
Novel Therapeutics Growth	122439.46%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2004 - 2008
Period Ending	Dec '24 Dec 31, 2024	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	2004 - 2008
United States	180.13M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	122439.46%	Log In	Log In	Log In	Log In	Upgrade